Economic Evaluation of Targeted Antifungal Treatment Sequencing Strategies For Invasive Aspergillosis Based on Real World Data: The Case f Dutch Clinical Practice

Invasive Aspergillosis(IA) is a serious invasive fungal infection(IFI), usually affecting immunocomprised patients. In the Netherlands, voriconazole(VOR) is the recommended primary targeted antifungal agent and is used for the vast majority of IA patients. After unsuccessful first line treatment with VOR, Caspofungin(CASP) and liposomal amphotericin B(L-AMB) are two most commonly used agents. In a previously published study, CASP was dominant over L-AMB, as a targeted salvage antifungal therapy option after VOR for IA treatment in the Netherlands.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: N Buyukkaramikli, M van Agthoven, A Leunis, JL Severens Source Type: research